Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 138 M131 M143 M169 M137 M 580 M Research & development ————— — Operating income 399 M304 M400 M187 M447 M 1.34 B Non-Operating Income, Total 3 M-18 M-10 M1 M-11 M -38 M Interest expense, net of interest capitalized 1 M01 M01 M 2 M Non-Operating Income, excl. Interest Expenses 2 M-18 M-11 M1 M-12 M -40 M Unusual income/expense ————— — Pretax income 428 M311 M413 M206 M452 M 1.38 B Equity in earnings 4 M2 M6 M3 M2 M 13 M Taxes 119 M80 M114 M56 M123 M 373 M Non-controlling/minority interest 21 M18 M23 M13 M22 M 76 M After tax other income/expense ————— — Net income before discontinued operations 292 M215 M282 M140 M309 M 946 M Discontinued operations ————— — Net income 292 M215 M282 M140 M309 M 946 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 292 M215 M282 M140 M309 M 946 M Basic earnings per share (Basic EPS) 0.780.580.760.40.88 2.62 Diluted earnings per share (Diluted EPS) 0.770.580.760.40.87 2.61 Average basic shares outstanding 376 M373 M368 M369 M353 M — Diluted shares outstanding 378 M374 M369 M371 M354 M — EBITDA 508 M414 M514 M302 M564 M 1.79 B EBIT 399 M304 M400 M187 M447 M 1.34 B Cost of revenue 2.28 B2.19 B2.48 B2.29 B2.49 B 9.45 B Other cost of goods sold 2.28 B2.19 B2.48 B2.29 B2.49 B 9.45 B Depreciation & amortization (cash flow) 109 M110 M114 M115 M117 M 456 M